Gilles Salles, MD, PhD
Memorial Sloan Kettering Cancer Center (MSK) has appointed Gilles Salles, MD, PhD, as Chief of the Lymphoma Service, Division of Hematologic Malignancies. He succeeds Anas Younes, MD.
Dr. Salles received his MD and PhD from the Université Claude Bernard Lyon and completed a residency in medicine at Lyon University Hospitals in Lyon, France. He also completed a postdoctoral fellowship at Harvard Medical School (Dana Farber Cancer Institute) in immunology. Since 1996, he has held the position of Professor of Medicine (Hematology) at the University Claude Bernard of Lyon and has served as Chair of the Department of Hematology at Lyon University Hospital since 2011.
For more than 20 years, Dr. Salles has been interested in the clinical and biological diversity of malignant lymphoma. Major focuses of his work include the description and validation of prognostic factors as well as clinical trials in indolent lymphomas and he has well over 600 peer reviewed publications. As an established international leader in the field of lymphoma, Dr. Salles has also led several programs and developed expertise in the clinical care of patients with lymphoma, development of novel clinical trials, and held numerous leadership positions.
He is well suited to continue to build and enhance a world-class medical Lymphoma Service at Memorial Sloan Kettering that is dedicated to patient care, medical research and teaching. Additionally, Dr. Salles plans to develop an ambitious translational research program and optimize the career development of our medical residents, fellows, and faculty.
Dr. Salles will work with institutional leadership to accomplish the strategic vision of the service and the goals to expand the clinical and research activities in lymphoma, maintain the highest standard of care, and expand and enrich the research program at MSK.
